As a matter of interest, the figures for FY11 were:
Revenue $410.4mil and EBIT $155.5mil
Whereas Mutt's base case figures for FY18 are:
Revenue $ 318.4mil and EBIT $125.9mil
Sounds like we're predicting figures of around 80% of FY11, so I'll be happy to take a dividend of 4c instead of 5c on FY18 results.
We certainly don't know of any major CapEx or other expenditure for FY18 besides the continued stripping of the West wall in the North Pit, which might cost $50mil and will be capitalised but Mutt's EBIT includes C1 cash costs that includes stripping cost so statutory EBIT for 2018 will be higher as the stripping cost is higher than D&A cost.
- Forums
- ASX - By Stock
- GRR
- Pellet Price
Pellet Price, page-177
-
- There are more pages in this discussion • 709 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add GRR (ASX) to my watchlist
(20min delay)
|
|||||
Last
23.5¢ |
Change
-0.005(2.08%) |
Mkt cap ! $266.1M |
Open | High | Low | Value | Volume |
24.0¢ | 24.5¢ | 23.5¢ | $96.74K | 403.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 311733 | 23.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
24.0¢ | 11914 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 219779 | 0.270 |
9 | 458580 | 0.265 |
26 | 932290 | 0.260 |
7 | 172530 | 0.255 |
22 | 717920 | 0.250 |
Price($) | Vol. | No. |
---|---|---|
0.275 | 405759 | 8 |
0.280 | 942702 | 17 |
0.285 | 372332 | 13 |
0.290 | 1710676 | 31 |
0.295 | 651900 | 8 |
Last trade - 16.10pm 22/11/2024 (20 minute delay) ? |
Featured News
GRR (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online